Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 79, Issue 3, 2008, Pages 427-432

  Iwasaki, Tomoyuki ^a   Togashi, Yu ^a   Ohshige, Kenji ^a   Yoneda, Masato ^a   Fujita, Koji ^a   Nakajima, Atsushi ^a   Terauchi, Yasuo ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Macrovascular complication; Metabolic syndrome; Microvascular complication

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROLIFERATIVE RETINOPATHY; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; VASCULAR DISEASE; WAIST CIRCUMFERENCE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY SIZE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROTEINURIA; RISK FACTORS; VASCULAR DISEASES; WAIST-HIP RATIO;

EID: 39549107129     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.10.035     Document Type: Article

References (20)

1. Reaven G.M. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Kim H.M., Kim D.J., Jung I.H., Park C., and Park J. Prevalence of the metabolic syndrome among Korean adults using the new International Diabetes Federation definition and the new abdominal obesity criteria for the Korean people. Diabetes Res. Clin. Pract. 77 (2007) 99-106
3. Yokoyama H., Kuramitsu M., Kanno S., Tada J., Yokota Y., and Kamikawa F. Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy. Diabetes Res. Clin. Pract. 75 (2007) 200-206
4. World Health Organization Report of a WHO Consultation, Part 1, Diagnosis and Classification of Diabetes Mellitus, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications, Geneva, World Health Organization, 1999.
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
6. Alberti K.G., Zimmet P., and Shaw J. IDF epidemiology task force consensus group, the metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
7. The Metascreen Writing Committee. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 29 (2006) 2701-2707
8. van den Hoogen P.C., Feskens E.J., Nagelkerke N.J., Menotti A., and Nissinen A. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world: Seven Countries Study Research Group. N. Engl. J. Med. 342 (2000) 1-8
9. Lee E.T., Keen H., Bennett P.H., Fuller J.H., and Lu M. Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity. Diabetologia 44 (2001) S3-S13
10. Sone H., Ito H., Ohashi Y., Akanuma Y., Yamada N., and Japan Diabetes Complication Study Group. Obesity and type 2 diabetes in Japanese patients. Lancet 361 (2003) 85
11. Expert Consultation W.H.O. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
12. Tan C.E., Ma S., Wai D., Chew S.K., and Tai E.S. Can we apply the National Cholesterol Education Program adult treatment panel definition of the metabolic syndrome to Asians?. Diabetes Care 27 (2004) 1182-1186
13. Deedwania P., Barter P., Carmena R., Fruchart J.C., Grundy S.M., Haffner S., et al. Treating to New Targets Investigators. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the treating to new targets study. Lancet 368 (2006) 919-928
14. Sone H., Tanaka S., Ishibashi S., Yamasaki Y., Oikawa S., Ito H., et al. Japan Diabetes Complications Study (JDCS) Group, The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: additional analysis from the Japan Diabetes Complications Study. Diabetes Care 29 (2006) 145-147
15. Sone H., Mizuno S., Fujii H., Yoshimura Y., Yamasaki Y., Ishibashi S., et al., Japan Diabetes Complications Study. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 28 (2005) 1463-1471
16. Davis M.D., Myers F.L., Bresnick G.H., and Venecia G. Natural evolution. In: L'Esperance Jr. F.A. (Ed). Current Diagnosis and Management of Chorioretinal Diseases (1977), St. Louis, MO, CV, Mosby 179-184
17. Alexander C.M., Landsman P.B., Teutsch S.M., Haffner S.M., and Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
18. Deurenberg P., Yap M., and van Staveren W.A. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int. J. Obes. Relat. Metab. Disord. 22 (1998) 1164-1171
19. Yoshiike N., Matsumura Y., Zaman M.M., and Yamaguchi M. Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990-1994. Int. J. Obes. Relat. Metab. Disord. 22 (1998) 684-687
20. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250